European and U.S. diabetologists called on Tuesday for greater caution in prescribing oral diabetes pills like GlaxoSmithKline Plc’s Avandia, which has been linked to increased heart attack risk.
In the light of the latest findings, the European Association for the Study of Diabetes and the American Diabetes Association said they had updated their “consensus statement” on use of oral anti-diabetics in patients with type 2 diabetes.
No User Responded In This Post
Leave Your Comments Here...